Cargando…

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice

BACKGROUND: Cardiovascular diseases (CVD) in diabetic patients have endothelial dysfunction as a key pathogenetic event. Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), plays a pivotal role in endothelial dysfunction. Different natural polyphenols have bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li Volti, Giovanni, Salomone, Salvatore, Sorrenti, Valeria, Mangiameli, Andrea, Urso, Vincenzo, Siarkos, Ilias, Galvano, Fabio, Salamone, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152512/ https://www.ncbi.nlm.nih.gov/pubmed/21756303 http://dx.doi.org/10.1186/1475-2840-10-62

Ejemplares similares

Silibinin Restores NAD(+) Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
por: Salomone, Federico, et al.
Publicado: (2017)

Silibinin Regulates Lipid Metabolism and Differentiation in Functional Human Adipocytes
por: Barbagallo, Ignazio, et al.
Publicado: (2016)

Molecular Bases Underlying the Hepatoprotective Effects of Coffee
por: Salomone, Federico, et al.
Publicado: (2017)

Asymmetric Dimethylarginine (ADMA) and Endothelial Dysfunction: Implications for Atherogenesis
por: Landim, Maurício Batista Paes, et al.
Publicado: (2009)

Blond and blood juice supplementation in high fat diet fed mice: effect on antioxidant status and DDAH/ADMA pathway
por: Sorrenti, V., et al.
Publicado: (2019)

The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
por: Sibal, Latika, et al.
Publicado: (2010)

Asymmetric Dimethylarginin (ADMA) as a Marker of Endothelial Dysfunction in Primary Aldosteronism
por: Matrozova, Joanna, et al.
Publicado: (2016)

Association of mortality and endothelial dysfunction with serum ADMA level in COVID-19 patients
por: Karacaer, Cengiz, et al.
Publicado: (2022)

Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals
por: Protopsaltis, Ioannis, et al.
Publicado: (2012)

Effect of Treatment with Cyanidin-3-O-β-D-Glucoside on Rat Ischemic/Reperfusion Brain Damage
por: Di Giacomo, Claudia, et al.
Publicado: (2012)

The Endothelial ADMA/NO Pathway in Hypoxia-Related Chronic Respiratory Diseases
por: Lüneburg, Nicole, et al.
Publicado: (2014)

Ibuprofen arginate retains eNOS substrate activity and reverses endothelial dysfunction: implications for the COX-2/ADMA axis
por: Kirkby, Nicholas S., et al.
Publicado: (2016)

Effects of ADMA upon Gene Expression: An Insight into the Pathophysiological Significance of Raised Plasma ADMA
por: Smith, Caroline L, et al.
Publicado: (2005)

Phosphate-Linked Silibinin Dimers (PLSd): New Promising Modified Metabolites
por: Romanucci, Valeria, et al.
Publicado: (2017)

ADMA: A Key Player in the Relationship between Vascular Dysfunction and Inflammation in Atherosclerosis
por: Dowsett, Laura, et al.
Publicado: (2020)

Dihydromyricetin Attenuates TNF-α-Induced Endothelial Dysfunction through miR-21-Mediated DDAH1/ADMA/NO Signal Pathway
por: Yang, Dafeng, et al.
Publicado: (2018)

Relationship between post-cardiac arrest myocardial oxidative stress and myocardial dysfunction in the rat
por: Hackenhaar, Fernanda Schäfer, et al.
Publicado: (2014)

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
por: Tsikas, Dimitrios, et al.
Publicado: (2018)

L-citrulline for protection of endothelial function from ADMA–induced injury in porcine coronary artery
por: Xuan, Chao, et al.
Publicado: (2015)

Iron Overload Damages the Endothelial Mitochondria via the ROS/ADMA/DDAHII/eNOS/NO Pathway
por: He, Huan, et al.
Publicado: (2019)

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality
por: Nijveldt, RJ, et al.
Publicado: (2003)

Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management
por: Salomone, Federico, et al.
Publicado: (2015)

Neurally mediated syncope: Is it really an endothelial dysfunction?
por: Dehghan, Bahar, et al.
Publicado: (2016)

Toxicity of Ochratoxin A and Its Modulation by Antioxidants: A Review
por: Sorrenti, Valeria, et al.
Publicado: (2013)

Dynamic Vessel Analyzer (DVA) – a new method to detect endothelial dysfunction in chronic heart failure: correlation between DVA and asymmetric dimethyl arginine (ADMA)
por: Schwefer, Markus, et al.
Publicado: (2011)

Crucial markers showing the risk of coronary artery disease in obesity: ADMA and neopterin
por: Avci, Emre, et al.
Publicado: (2020)

Protective role of silibinin against myocardial ischemia/reperfusion injury-induced cardiac dysfunction
por: Chen, Yi-He, et al.
Publicado: (2020)

Silibinin as potential tool against SARS‐Cov‐2: In silico spike receptor‐binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects
por: Speciale, Antonio, et al.
Publicado: (2021)

ADMA in Vascular Disease: More than a Marker?
Publicado: (2005)

Biomarkers of endothelial dysfunction in relation to impaired carbohydrate metabolism following pregnancy with gestational diabetes mellitus
por: Göbl, Christian S, et al.
Publicado: (2014)

Wound Healing Activity of Silibinin in Mice
por: Samanta, Rojalini, et al.
Publicado: (2016)

Silibinin: an old drug for hematological disorders
por: Zou, Hai, et al.
Publicado: (2017)

Silibinin and non-melanoma skin cancers
por: Prasad, Ram Raj, et al.
Publicado: (2020)

Inhibition of Phagocytosis by Silibinin in Mouse Macrophages
por: Sun, Kyung-Hoon, et al.
Publicado: (2023)

Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence
por: Castellaneta, Antonino, et al.
Publicado: (2016)

Association of Endothelial Dysfunction and Antiretroviral Therapy in Early HIV Infection
por: Bush, Kelvin N. V., et al.
Publicado: (2019)

Silibinin, an HSP90 Inhibitor, on Human ACTH-Secreting Adenomas
por: Pecori Giraldi, Francesca, et al.
Publicado: (2023)

Actin cytoskeleton modulates ADMA-induced NF-kappaB nuclear translocation and ICAM-1 expression in endothelial cells
por: Wei-Kang, Guo, et al.
Publicado: (2011)

ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease
por: Janes, Francesco, et al.
Publicado: (2019)

Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease
por: Franceschelli, Sara, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rl3p22ickke04e3a8l52iblv5c